Search stocks

Find any stock by ticker or company name

Home

CYTK

Cytokinetics, Incorporated (CYTK)

NMS – Real vaqt narxi. Valyuta: USD

75.76

-0.69 (-0.90%)

Bozor ochiq: Aug 12, 2026, 3:26 PM EDT

76.67

+0.22 (0.29%)

Oldingi bozordan keyin: Aug 11, 2026, 7:35 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

CYTK - Cytokinetics, Incorporated So'nggi... | Finranks

Home

CYTK

Cytokinetics, Incorporated (CYTK)

NMS – Real vaqt narxi. Valyuta: USD

75.76

-0.69 (-0.90%)

Bozor ochiq: Aug 12, 2026, 3:26 PM EDT

76.67

+0.22 (0.29%)

Oldingi bozordan keyin: Aug 11, 2026, 7:35 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

07.08.2026

CYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong

CYTK tops Q2 revenue estimates as Myqorzo gains traction, but higher launch costs and the absence of milestone payments weigh on results.

07.08.2026

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

07.08.2026

Cytokinetics Q2 Earnings Call Highlights

Cytokinetics NASDAQ: CYTK reported second-quarter results marked by early commercial momentum for MYQORZO, international market-access progress and plans to seek an expanded indication for aficamten in non-obstructive hypertrophic cardiomyopathy, or nHCM.

06.08.2026

Cytokinetics (CYTK) Reports Q2 Loss, Beats Revenue Estimates

Cytokinetics (CYTK) came out with a quarterly loss of $1.5 per share versus the Zacks Consensus Estimate of a loss of $1.63. This compares to a loss of $1.12 per share a year ago.

Videolar

No Data

There is no data to display